Tang Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Tang Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$114M	Hold	1,236,027	–	–	5.8%	3
2025 Q4	$97.6M	Hold	1,236,027	–	–	4.82%	5
2025 Q3	$90.6M	Hold	1,236,027	–	–	3.49%	5
2025 Q2	$62.9M	Sell	1,236,027 -1,080	-0.1%	-$48.1K	3.18%	6
2025 Q1	$55.7M	Hold	1,237,107	–	–	3.08%	8
2024 Q4	$51.2M	Sell	1,237,107 -50,000	-4%	-$2.08M	3.38%	5
2024 Q3	$50.2M	Hold	1,287,107	–	–	3.59%	5
2024 Q2	$44M	Buy	1,287,107 +100,000	+8%	+$2.62M	4.48%	4
2024 Q1	$29.8M	Buy	1,187,107 +50,000	+4%	+$1.37M	3.1%	5
2023 Q4	$33.6M	Hold	1,137,107	–	–	3.1%	7
2023 Q3	$35.9M	Hold	1,137,107	–	–	5.07%	2
2023 Q2	$29.4M	Sell	1,137,107 -32,893	-3%	-$875K	4.33%	3
2023 Q1	$28.1M	Buy	1,170,000 +50,000	+4%	+$1.14M	4.19%	3
2022 Q4	$21.8M	Buy	1,120,000 +670,000	+149%	+$13.2M	3.17%	9
2022 Q3	$9.46M	Buy	450,000 +350,000	+350%	+$8.43M	1.16%	25
2022 Q2	$1.95M	Buy	+100,000	New	+$2.36M	0.3%	50

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Tang Capital Management's MIRM Position: Q1 2026 in Review

Tang Capital Management held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 1,236,027 shares worth $114M. The position accounts for 5.8% of the portfolio, ranked #3.

Tang Capital Management first reported a position in MIRM in Q2 2022 and has held it in 16 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Tang Capital Management held 1,236,027 shares of Mirum Pharmaceuticals worth $114M as of Q1 2026.
Tang Capital Management left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
Mirum Pharmaceuticals made up 5.8% of Tang Capital Management's portfolio in Q1 2026, its #3 holding.
Tang Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.